| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| 1,3-Benzenedicarbonitrile, 4-ethoxy- |
非布司他雜質(zhì) |
161718-82-7 |
詳細(xì)
|
| 5-CHLOROSULFONYL-2-ETHOXYBENZOIC ACID |
5-氯磺?；?2-乙氧基苯甲酸（西地那非雜質(zhì)） |
200575-16-2 |
詳細(xì)
|
| OmeprazoleN-oxide |
奧美拉唑N-氧化物 |
176219-04-8 |
詳細(xì)
|
| Febuxostat Impurity E |
非布司他雜質(zhì)E |
923942-34-1 |
詳細(xì)
|
| Parecoxib Impurity C（Valdecoxib Impurity） |
帕瑞昔布雜質(zhì)C |
198471-06-6 |
詳細(xì)
|
| N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)isobutyramide(PalbociclibImpurity) |
N-((4-(5-甲基-3-苯基異噁唑-4-基)苯基)磺酰基)異丁酰胺（帕瑞昔布鈉雜質(zhì)） |
198470-82-5 |
詳細(xì)
|
| glycocholic acid ethyl ester |
甘氨膽酸乙酯 |
517904-33-5 |
詳細(xì)
|
| Parecoxib Impurity |
帕瑞昔布雜質(zhì)Q |
2749361-92-8 |
詳細(xì)
|
| 2-chloro-N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo [2,3-d]pyrimidin-4-amine |
托法替尼雜質(zhì)31 |
1616760-97-4 |
詳細(xì)
|
| Trelagliptin Impurity |
曲格列汀雜質(zhì) |
1917324-14-1 |
詳細(xì)
|
| 16alpha-Hydroxyprednisonlone acetate |
16α羥基潑尼松龍醋酸酯（布地奈德雜質(zhì)） |
86401-80-1 |
詳細(xì)
|
| Febuxostat Impurity 48;diethyl 2,2'-(4-formyl-6-hydroxy-1,3-phenylene)bis(4-methylthiazole-5-carboxylate) |
非布索坦雜質(zhì)48（非布司他雜質(zhì)） |
2375033-35-3 |
詳細(xì)
|
| Trelagliptin Impurity |
曲格列汀雜質(zhì) |
2088203-83-0 |
詳細(xì)
|
| Argatroban impurity J |
阿加曲班雜質(zhì)J |
1780572-69-1 |
詳細(xì)
|
| 1-{4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-ethanone |
甲酰托法替尼 |
344418-61-7 |
詳細(xì)
|
| 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile |
托法替尼 |
477600-75-2 |
詳細(xì)
|
| Ethyl2-(3-Formyl-4-isobutoxyphenyl)-4-Methylthiazole-5-Carboxylate |
2-(3-醛基-4-異丁氧基苯基)-4-甲基噻唑-5-甲酸乙酯（非布司他雜質(zhì)） |
161798-03-4 |
詳細(xì)
|
| Febuxostat Impurity Z17 |
非布索坦雜質(zhì)Z17（非布司他雜質(zhì)） |
161798-01-2 |
詳細(xì)
|
| 2-(5-cyano-2-isobutoxyphenyl)-4-methylthiazole-5-carboxylic acid |
非布索坦雜質(zhì)38（非布司他雜質(zhì)） |
528607-60-5 |
詳細(xì)
|
| Parecoxib Impurity E |
帕瑞昔布鈉雜質(zhì)E |
1373038-59-5 |
詳細(xì)
|
| 2-amino-2-(2-chlorophenyl)acetamide |
硫酸氫氯吡格雷雜質(zhì)3 |
1198220-10-8 |
詳細(xì)
|
| Ethyl2-oxo-2-(pyridin-2-ylamino)acetate(EdoxabanImpurity) |
2-氧代-2-(吡啶-2-基氨基)乙酸乙酯（依度沙班雜質(zhì)） |
41374-72-5 |
詳細(xì)
|
| Trelagliptin Impurity 3 |
曲格列汀雜質(zhì)3 |
1812193-01-3 |
詳細(xì)
|
| 4-Hydroxyisophthalonitrile |
2,4-二氰基苯酚（非布司他雜質(zhì)） |
34133-58-9 |
詳細(xì)
|
| 1-(6-Nitropyridin-3-yl)piperazine |
1-(6-硝基吡啶-3-基)哌嗪 |
775288-71-6 |
詳細(xì)
|
| Febuxostat Intermediate |
2-[3-氰基-4-異丁氧基苯基]-4-甲基噻唑-5-甲酸乙酯（非布司他中間體6） |
160844-75-7 |
詳細(xì)
|
| Parecoxib Impurity 21 |
帕瑞昔布鈉雜質(zhì)21 |
1884279-18-8 |
詳細(xì)
|
| Febuxostat Impurity 41;4-hydroxybenzothioamide |
非布索坦雜質(zhì) 41（非布司他雜質(zhì)） |
2428631-67-6 |
詳細(xì)
|
| Cetirizine IMpurity D |
西替利嗪雜質(zhì)D |
346451-15-8 |
詳細(xì)
|
| glycylglycocholicacid |
甘氨甘氨膽酸 |
26563-58-6 |
詳細(xì)
|
| Omeprazole Impurity 8 |
奧美拉唑雜質(zhì)47 |
848694-10-0 |
詳細(xì)
|
| Prednisone 17, 21-Diacetate |
潑尼松雜質(zhì) |
6677-19-6 |
詳細(xì)
|
| Glycine,N-(aminoiminomethyl)-N-methyl-, ethyl ester |
肌酸乙酯 |
15366-29-7 |
詳細(xì)
|
| 3-[(3R,4R)-3-({2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl}(methyl)amino)-4-methylpiperidin-1-yl]-3-oxopropanenitrile |
托法替尼雜質(zhì)68 |
1616761-00-2 |
詳細(xì)
|
| Prednisolone, 9-bromo-6.alpha.-methyl-, 21-acetate |
氟米龍雜質(zhì) |
93052-90-5 |
詳細(xì)
|
| VMPHCYUBONNNJN-ZHCMNPPYSA-N |
潑尼松EP雜質(zhì)J |
78261-67-3 |
詳細(xì)
|
| Febuxostat Impurity 40 |
非布司他雜質(zhì)40 |
7133-90-6 |
詳細(xì)
|
| MEDROXYPROGESTERONE |
甲孕酮 |
520-85-4 |
詳細(xì)
|
| ethyl 2-(3-formyl-4-isopropoxyphenyl)-4-methylthiazole-5-carboxylate |
非布索坦雜質(zhì)46（非布司他雜質(zhì)） |
2230270-05-8 |
詳細(xì)
|
| ethyl 2-(3,5-diformyl-4-hydroxyphenyl)-4-methylthiazole-5- carboxylate |
非布索坦雜質(zhì)39（非布司他雜質(zhì)） |
2073891-59-3 |
詳細(xì)
|
| Tipiracil Impurity 2 |
替比嘧啶雜質(zhì)C |
2101241-71-6 |
詳細(xì)
|
| Trelagliptin Impurity |
曲格列汀雜質(zhì) |
1938080-43-3 |
詳細(xì)
|
| 5-Thiazolecarboxylic acid, 2-[3,5-diformyl-4-(2-methylpropoxy)phenyl]-4-methyl-, ethyl ester |
非布司他雜質(zhì)80 |
2375033-26-2 |
詳細(xì)
|
| 1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-3-(1-ethylpropoxy)-5-[2-formyl-5-(hydroxymethyl)-1H-pyrrol-1-yl]-, ethyl ester, (4R,5S)-rel- |
奧司他韋雜質(zhì) |
2434599-55-8 |
詳細(xì)
|
| Gonan-3-one, 17-hydroxy-, (5α,17β)- (9CI) |
睪酮雜質(zhì) |
200056-72-0 |
詳細(xì)
|
| 5-Thiazolecarboxylic acid, 2-(4-hydroxy-3-methylphenyl)-4-methyl-, ethyl ester |
非布司他雜質(zhì) |
1621995-80-9 |
詳細(xì)
|
| 1-Piperazinecarboxaldehyde, 4-[2-[(2,4-dimethylphenyl)sulfinyl]phenyl]- |
沃替西汀雜質(zhì) |
2425618-48-8 |
詳細(xì)
|
| Parecoxib Impurity B |
帕瑞昔布鈉雜質(zhì)B |
181696-35-5 |
詳細(xì)
|
| (S)-2-(3,4-Difluorophenyl)oxirane |
替格瑞洛雜質(zhì) 100 |
1006376-63-1 |
詳細(xì)
|
| Epoxy Metradiene |
氟米龍雜質(zhì) |
83873-16-9 |
詳細(xì)
|
| 4,6-dichloro-2-(propylsulfinyl)pyriMidin-5-aMine |
替格瑞洛雜質(zhì)30 |
1823431-32-8 |
詳細(xì)
|
| Testosterone Propionate EP Impurity B |
丙酸睪酮EP雜質(zhì)B |
1169-49-9 |
詳細(xì)
|
| Clopidogrel Impurity 13 HCl;methyl 2-(2-chlorophenyl)-2-((2-(thiophen-2-yl)ethyl)amino)acetate hydrochloride |
氯吡格雷雜質(zhì)13 |
2173294-69-2 |
詳細(xì)
|
| Trelagliptin Impurity 5 |
曲格列汀雜質(zhì) |
2087874-92-6 |
詳細(xì)
|
| Fluorometholone Impurity 5 |
氟米龍雜質(zhì) 5 |
110664-58-9 |
詳細(xì)
|
| Valdecoxib |
代他考昔 |
181695-72-7 |
詳細(xì)
|
| Omeprazole Sulfide |
奧美拉唑硫醚（埃索美拉唑雜質(zhì)C） |
73590-85-9 |
詳細(xì)
|
| Ambroxol EP Impurity B |
氨溴索EP雜質(zhì)B |
15942-08-2 |
詳細(xì)
|
| Esomeprazole Impurity 29 |
埃索美拉唑雜質(zhì)29 |
704910-89-4 |
詳細(xì)
|
| (1S,2S,3R,5S)-3-(7-hydroxy-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
替格瑞洛羥基雜質(zhì) |
1445580-43-7 |
詳細(xì)
|
| ethyl 2-(3-formyl-2-isobutoxyphenyl)-4-methylthiazole-5- carboxylate |
非布索坦雜質(zhì)32（非布司他雜質(zhì)） |
1805770-41-5 |
詳細(xì)
|
| Tinidazole Impurity B |
替硝唑雜質(zhì)B |
25459-12-5 |
詳細(xì)
|
| Pregna-1,4-diene-3,11,20-trione, 17-(acetyloxy)-21-hydroxy- |
潑尼松雜質(zhì) |
95440-71-4 |
詳細(xì)
|
| OmeprazolesulfoneN-Oxide |
奧美拉唑砜N-氧化物 |
158812-85-2 |
詳細(xì)
|
| 11β-Hydroxyandrost-4-ene-3,17-dione |
11β-羥基雄甾-4-烯-3,17-二酮（氫化可的松雜質(zhì)） |
382-44-5 |
詳細(xì)
|
| 5-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-5,6,7,7a-tetra hydrothieno[3,2-c]pyridin-2(4H)-one |
5-[2-環(huán)丙基-1-(2-氟苯基)-2-氧代乙基]-5,6,7,7-1-四氫噻吩并[3,2-c]吡啶-2(4H)-酮（普拉格雷雜質(zhì)） |
150322-38-6 |
詳細(xì)
|
| Trelagliptin Impurity S |
曲格列汀雜質(zhì)S |
1917324-15-2 |
詳細(xì)
|
| Trelagliptin Impurity X |
曲格列汀雜質(zhì)X |
1938080-44-4 |
詳細(xì)
|
| Tofacitinib Impurity 5 |
托伐替尼雜質(zhì)5 |
2250243-18-4 |
詳細(xì)
|
| Ticagrelor Impurity16 |
替格瑞洛雜質(zhì)16 |
2518048-22-9 |
詳細(xì)
|
| 1H-Pyrazole-5-carboxamide, 4-[[2-hydroxy-5-[(4-methyl-1-piperazinyl)sulfonyl]benzoyl]amino]-1-methyl-3-propyl- |
西地那非雜質(zhì) |
960009-36-3 |
詳細(xì)
|
| 1,2-Cyclopentanediol, 3-[7-[[(1S,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-, (1R,2R,3S,5R)- |
替格瑞洛雜質(zhì) |
2435586-41-5 |
詳細(xì)
|
| 6-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfonyl}-1H-benzimidazole |
埃索美拉唑EP雜質(zhì)D |
1810066-05-7 |
詳細(xì)
|
| Homopiperazine |
高哌嗪 |
505-66-8 |
詳細(xì)
|
| 1-Boc-4-(6-nitropyridin-3-yl)piperazine |
4-(6-硝基-3-吡啶基)-1-哌嗪甲酸叔丁酯（依度沙班雜質(zhì)） |
571189-16-7 |
詳細(xì)
|
| 11-Oxo-betaMethasone Dipropionate |
11-氧-倍他米松二丙酸酯 |
64967-90-4 |
詳細(xì)
|
| Benzonitrile, 2-[[6-[(3R)-3-[[(2-cyano-5-fluorophenyl)methyl]amino]-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-4-fluoro- |
曲格列汀雜質(zhì) |
2412663-46-6 |
詳細(xì)
|
| Androsta-1,4-diene-17-carboxylic acid, 11-hydroxy-17-[(methoxycarbonyl)oxy]-3-oxo-, (11β,17α)- (9CI) |
氯替潑諾雜質(zhì) |
265651-76-1 |
詳細(xì)
|
| Pyrido[3,2-d]pyrimidin-6(5H)-one, 5-cyclopentyl-8-methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]- |
帕布昔利布雜質(zhì) |
2745066-17-3 |
詳細(xì)
|
| Omeprazole Impurity 1 |
奧美拉唑雜質(zhì)1 |
103877-02-7 |
詳細(xì)
|
| 2-(((6-methoxy-1H-benzo[d]imidazol-2-yl)thio)methyl)-3,5- dimethylpyridin-4-ol |
埃索美拉唑雜質(zhì)H215前體 |
103876-98-8 |
詳細(xì)
|
| Febuxostat Impurity 47 |
非布司他雜質(zhì)47 |
161718-85-0 |
詳細(xì)
|
| 4-methoxy-2-(((5-methoxy-1H-benzo[d]imidazol-2-yl)thio)methyl)-3,5-dimethylpyridine 1-oxide |
埃索美拉唑雜質(zhì)E01 |
142885-92-5 |
詳細(xì)
|
| Clobetasone Butyrate EP Impurity I |
丁酸氯倍他松EP雜質(zhì)I |
639817-47-3 |
詳細(xì)
|
| Febuxostat Impurity 3 |
非布索坦雜質(zhì)3（非布司他雜質(zhì)） |
161798-02-3 |
詳細(xì)
|
| 2-(Chloromethyl)-3,5-dimethylpyridin-4-ol |
2-(氯甲基)-3,5-二甲基吡啶-4-醇（奧美拉唑雜質(zhì)） |
220771-03-9 |
詳細(xì)
|
| 2-[(RS)-[(3,5-dimethylpyridin-2-yl)methyl]sulfinyl]-5- methoxy-1H-benzimidazole |
4-去甲氧基奧美拉唑（埃索美拉唑雜質(zhì)B） |
110374-16-8 |
詳細(xì)
|
| (1R)-2-chloro-1-(3,4-difluorophenyl)-1-ethanol |
替格瑞洛雜質(zhì)89 |
1212376-05-0 |
詳細(xì)
|
| 5-Methoxy-2-mercaptobenzimidazole |
2-巰基-5-甲氧基苯并咪唑（埃索美拉唑相關(guān)化合物） |
37052-78-1 |
詳細(xì)
|
| 2-Mercapto-1H-benzo[d]imidazol-5-ol |
2-巰基-1H-苯并[d]咪唑-5-醇（埃索美拉唑雜質(zhì)） |
92806-98-9 |
詳細(xì)
|
| N2-(tert-Butoxycarbonyl)-Nw-nitro-D-arginine |
N2-(叔丁氧羰基)-Nw-硝基-D-精氨酸（阿加曲班雜質(zhì)） |
50913-12-7 |
詳細(xì)
|
| (3R,4R)-1-(2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-N,4-dimethylpiperidin-3-amine |
托法替尼-imZ22 |
2504210-32-4 |
詳細(xì)
|
| Pregna-1,4,9(11)-triene-3,20-dione, 17-hydroxy- |
氟米龍雜質(zhì) |
30934-01-1 |
詳細(xì)
|
| 4-(5-Methyl-3-phenylisoxazol-4-yl)-N-((4-(5-methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)benzenesulfonamide(PalbociclibImpurity) |
4-(5-甲基-3-苯基異惡唑-4-基)-N-((4-(5-甲基-3-苯基異噁唑-4-基)苯基)磺?；?苯磺酰胺（帕瑞昔布鈉雜質(zhì)） |
1373038-60-8 |
詳細(xì)
|
| Trelagliptin Impurity 5 |
琥珀酸曲格列汀雜質(zhì)233 |
1971613-57-6 |
詳細(xì)
|
| 4,5''-Di(desmethyl) Omeprazole Sulfide |
4,5''-二去甲基奧美拉唑硫化物（奧美拉唑雜質(zhì)42） |
176219-12-8 |
詳細(xì)
|
| Hydrocortisone impurity J (EP) |
氫化可松EP雜質(zhì)J |
16463-74-4 |
詳細(xì)
|
| INDEX NAME NOT YET ASSIGNED |
替格瑞洛雜質(zhì) |
2681352-85-0 |
詳細(xì)
|
| N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)butyramide(PalbociclibImpurity) |
N-((4-(5-甲基-3-苯基異噁唑-4-基)苯基)磺?；?丁酰胺（帕瑞昔布鈉雜質(zhì)） |
198470-91-6 |
詳細(xì)
|
| 1H-Imidazole, 1-[2-(ethylsulfinyl)ethyl]-2-methyl-5-nitro- |
替硝唑雜質(zhì) |
2376335-05-4 |
詳細(xì)
|